site stats

Biotheranostics logo

WebFeb 22, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics, Inc. for approximately $230 million.Biotheranostics develops and markets two highly differentiated molecular … WebJun 29, 2024 · Biotheranostics, the company that makes the Breast Cancer Index test, has a Patient Services Team to help you with verifying insurance coverage and understanding any out-of-pocket costs. The company also has a patient assistance program that helps pay for testing. To contact the Patient Services Team, call 1-844-319-8111.

Biotheranostics Inc. to Pay $2 Million Settlement …

WebBiotheranostics privacy statement. This privacy statement governs your use of Biotheranostics’s website and all information you provide to Biotheranostics on our website. This Notice of privacy practices describes how Biotheranostics may use and disclose individuals’ health information, whether collected on our website or off-line, and … WebFeb 22, 2024 · - Breast Cancer Index ™ Added to National Comprehensive Cancer Network Guidelines to Predict Benefit from Extended Endocrine Therapy - Hologic, Inc. (Nasdaq: … ioh building https://cdmestilistas.com

Biotheranostics CancerTYPE ID aids in patient selection for

WebBiotheranostics is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that support physicians in the … WebJan 13, 2016 · About bioTheranostics bioTheranostics, Inc., is a leader in helping physicians improve the care of cancer patients, offering a suite of proprietary molecular diagnostic tests that allow treatment ... WebSep 21, 2024 · Biotheranostics, Inc., is a leading healthcare provider in the oncology field assisting physicians in the treatment of cancer patients. Its suite of commercially available proprietary molecular ... on stage lighting clamp

Hologic to buy privately held cancer-test maker for $230 million

Category:Hologic

Tags:Biotheranostics logo

Biotheranostics logo

Biotheranostics, Inc., A Hologic Company LinkedIn

WebDec 8, 2024 · Biotheranostics, Inc. operates a CLIA-certified and CAP-accredited diagnostic laboratory in San Diego, California. Biotheranostics, Inc., is a leading healthcare provider in the oncology field ... WebBiotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to support personalized disease management in … Biotheranostics Nondiscrimination Notice. Download our PDF to view this notice in …

Biotheranostics logo

Did you know?

WebFeb 22, 2024 · Biotheranostics also developed and markets the CancerTYPE ID test, which provides a molecular diagnosis for patients with uncertain or unknown cancers. In advanced cancer that has metastasized, it ... WebJan 5, 2024 · Biotheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support …

WebMar 13, 2024 · Biotheranostics doesn't have any recent trademark applications, indicating Biotheranostics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and …

WebApr 1, 2024 · Biotheranostics, Inc. operates a CLIA-certified and CAP-accredited diagnostic laboratory in San Diego, California. Biotheranostics, Inc., is a leading healthcare provider in the oncology field ... WebJan 5, 2024 · – Transaction Accelerates Hologic’s Entry into Oncology Growth Market, Provides New Lab Capabilities – – Hologic’s Commercial Resources, Expertise in …

WebApr 19, 2024 · The United States alleged that Biotheranostics Inc. — a diagnostic laboratory testing company — knowingly promoted and performed the Breast Cancer Index test for breast cancer patients who …

WebMar 15, 2007 · About BIOTHERANOSTICS, INC. Biotheranostics, Inc. is a provider established in San Diego, California operating as a Clinical Medical Laboratory.The NPI … on-stage lighting standsWebCancerTYPE ID ® is a proprietary molecular assay using RT-PCR to measure expression of 92 genes. To classify the tumor, the gene expression profile is matched to a database of more than 2000 known tumor types and subtypes. Using this technology, CancerTYPE ID ® can identify 50 different tumor types and subtypes, covering >95% of all solid ... on stage light boxWebBeing part of Hologic only helps bring that hope closer to reality. In addition, patients facing the challenges of metastatic cancer will have broader access to our CancerTYPE ID … onstage login rocWebJan 6, 2024 · Published. Jan 6, 2024 1:28AM EST. M edical technology company Hologic Inc. has announced the acquisition of privately-held Biotheranostics Inc. in a deal worth $230 million. Shares of Hologic ... on stage lighting assemblyhttp://www.biotheranostics.com/ onstage loginWebThis test is used for clinical purposes, and should not be regarded as experimental or investigational. How this information is used to guide patient care is the responsibility of the treating provider. Biotheranostics is certified under the Clinical Laboratory Improvement Amendments of 1988 to perform high complexity clinical laboratory testing. ioh charityWebThis test is used for clinical purposes, and should not be regarded as experimental or investigational. How this information is used to guide patient care is the responsibility of … iohcp